Search

Combined use of a hearing aid and a cochlear implant: a case study

When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

Drug side-effects on audiological and vestibular testing

Are they a malingerer? Or perhaps they are inattentive? It may be their drugs! Robert DiSogra considers the side-effects of medication on the test subject. The audiogram serves many purposes in clinical practice. For the audiologist, it helps to differentiate...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

What has NAIROS taught us about septoplasty?

Septoplasty is a commonly performed procedure worldwide for nasal obstruction associated with a deviated nasal septum. In the UK, with long waiting lists for septoplasty, there is a large and unexplained variation in the incidence of this procedure between individual...

Cochlear implant care: putting patients in charge

Should patients take charge of their own cochlear implant care? Helen Cullington presents a compelling case that will provoke discussion in implant centres. Around 1400 people receive a cochlear implant in the UK each year. Patients require lifetime annual follow-up...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

How cognition influences hearing aid use

Introduction Hearing aids are designed to provide amplification for individuals with poor auditory sensitivity. Signal processing algorithms are designed and implemented in hearing aids to further enhance speech intelligibility and to improve listening comfort by attenuating unwanted background noise. Sarampalis...